Extended Data Fig. 7: Covariate-adjusted hazard ratios of COVID-19 per 10-fold increase in each Day 29 antibody marker in baseline SARS-CoV-2 seronegative per-protocol vaccine recipients in subgroups.
From: Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
The error bars show the 95% confidence intervals. Baseline covariates adjusted for were baseline risk score and geographic region.
